Results for radjukimika translation from Maltese to English

determinazzjoni tal-purità radjukimika ta’ lymphoseek radjutikkettat
determination of radiochemical purity of radiolabelled lymphoseek

ikkalkula l-perċentwal ta’ purità radjukimika (% rcp) kif ġej:
calculate the percent radiochemical purity (% rcp) as follows:

iddetermina l-purità radjukimika tal-prodott radjutikkettat kif deskritt hawn taħt.
determine the radiochemical purity of the radiolabelled product as described below.

5) ikkalkula l- medja ta ’ purità radjukimika (rcp) hekk:
5.) calculate the average radiochemical purity (rcp) as follows:

għall- ogħla purità radjukimika, irrikostitwixxi b’elużjoni ta’ ġeneratur technetium tc 99m elwita friska.
for the highest radiochemical purity, reconstitute with freshly eluted technetium tc 99m generator eluate.

għal istruzzjonijiet fuq it-tħejjija u l-kontroll tal-purità radjukimika tar-radjufarmaċewtiku, ara sezzjoni 12.
for instructions for preparation and control of the radiochemical purity of the radiopharmaceutical, see section 12.

jekk il- purità radjukimika tkun inqas minn 95%, din is- sustanza m’ għandiex tingħata lill- pazjent.
if the average radiochemical purity is less than 95%, the preparation should not be administered.

jekk il- purità radjukimika medja tkun ta ’ inqas minn 95%, din it- taħlta ma għandhiex tingħata lill - pazjent.
if the average radiochemical purity is less than 95%, the preparation should not be administered.

wara li jigi ppreparat, il- purezza radjukimika ghandha tigi ddeterminata b ’ instant thin layer chromatography fuq gel tas- silica fuq fiibri tal- hgieg.
after radiolabelling the antibody and diluting a 10 µl sample with 1.5 ml saline, immediately determine the radiochemical purity by instant thin layer chromatography on silica gel impregnated glass fiber strips, 1 × 9 cm using acetone as the solvent.

is- sigurta` u l- effett ta '99mtc- depreotide kienu stabbiliti bl- użu ta' materjal investigattiv li ntwera li kellu safa radjukimika ta 'mill- inqas 90% bl- itlc qabel ma ngħata lill- pazjenti fi studji kliniċi.
safety and effectiveness of 99mtc-depreotide were established using investigational material shown to have a radiochemical purity of at least 90% by itlc prior to administration to patients in clinical studies.